120 likes | 265 Views
ACPE Fall Institute: Capstone Project. Brian McDonough, MD CMIO: St. Francis Hospital Chairman: CHE Pharmacy and Therapeutics Committee. Capstone Project. Chair Pharmacy and Therapeutics Committee for Catholic Health East Standardize Pharmacy to Match Standardized Order Sets
E N D
ACPE Fall Institute: Capstone Project Brian McDonough, MD CMIO: St. Francis Hospital Chairman: CHE Pharmacy and Therapeutics Committee
Capstone Project • Chair Pharmacy and Therapeutics Committee for Catholic Health East • Standardize Pharmacy to Match Standardized Order Sets • Estimated Six Thousand Medications • Estimated 350 Million Dollar Pharmacy Distributed Among East Coast Regional Health Centers
Barriers • “Buy In” From The Regional Health Centers • Creating A Strong Relationship With Various P&T Committees • Developing Formulary and Evaluating Six Thousand Medications
Communication Is Top Priority • Open lines of communication between the corporate pharmacists and those at the Regional Health Centers (RHCs) • Monthly meetings, personal visits and regular phone conversations, email and power point updates
Ongoing Communication • Find mutual needs of each group and bring them together using the power of the PTC to help meet those needs • With the understanding that this is an ever changing project, help bridge the gap between changing corporate guidelines and RHC response and needs
Development of Calendar • It is essential to have a calendar to use as a guide for the entire Pharmacy and Therapeutics Committee to follow • It is understood that this calendar will be fluid in nature based on ever changing demands • Representatives of RHCs need to have a clear voice in approval and development of this calendar
Formulary Development • Leverage Resources From RHCs • Interview Pharmacists From Each RHC To Determine Areas Of Interest Recognizing That Local RHCs Have Selected Medications Through Committee And Evidence Based Decisions
Formulary Development • The formulary shall be reviewed at least annually • The selection and deletion of formulary items shall be based upon objective evaluation of their relative therapeutic merits, safety, and estimated cost
Ongoing Roles • Monitor and evaluate adverse drug reactions and medication errors; make appropriate recommendations for system changes to prevent such occurrences • Develop programs and procedures that help ensure ongoing cost-effective use of drugs with emphasis placed on clinical effectiveness, safety and the total cost of therapy
Ongoing Roles • Develop and monitor policies involving restrictions placed on the use of formulary and non-formulary drugs at CHE • Provide professional and scientific input to the service and education functions of the Department of Pharmacy • Educate physicians and other professional staff on matters pertaining to the use of drugs
Ongoing Roles • Serve in an evaluative, educational, and advisory capacity to healthcare providers and hospital administration in matters pertaining to the use of drugs • Develop a universal formulary policy and universal formulary associated standards of practice
Ongoing Roles • Keep an eye toward defining formulary medication based on technical and operational feasibility as well as consistency with universal formulary policy • Successful implementation at the RHC level of policies and procedures reviewed and approved by PTC